Particulars |
|
|
|
Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202503
|
Full Year |
Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
308.10 |
Sales(₹ Cr.) |
1,716.29 |
NP (₹ Cr.) |
175.13 |
NP Var (%) |
17.00 |
Div% |
1,600.00 |
CPS(₹) |
86.00 |
EPS (₹) |
70.10 |
Traded Value(₹ Lakhs) |
856.55 |
52 Week High |
10,653.00 |
52 Week Low |
6,222.00 |
Price BSE |
9,291.00 |
Price NSE |
9,340.00 |
Market Capital (₹ Cr.) |
23,227.50 |
P/C Ratio |
108.00 |
P/E Ratio |
132.60 |
Price Vs.BV |
30.16 |
|
Latest Quarter |
Year End |
202503 |
Sales (₹ Cr.) |
480.48 |
NP(₹ Cr.) |
62.27 |
NP Var % |
58.00 |
Trailing Twelve Months |
Year End |
202503 |
Sales |
1,484.51 |
OPM |
4.15 |
NP |
128.73 |
NP Var (%) |
17.49 |
EPS |
70.05 |
PE |
132.63 |
|
|